Table 3.

Type of pre-transplant infection in patient with a VAD

Infections	VAD patients n = 18
Total number of VAD-specific or related infectionsa	n = 43
VAD-specific infections; n (%)  • Proteus mirabilis  • Enterobacter spp.  • Staphylococcus aureus   • MSSA   • MRSA  • Coagulase-negative Staphylococci  • Escherichia coli   • ESBL  • Serratia marcescens  • Enterococcus faecalis   • VRE  • Other	24 (55.8) 6 (13.9) 4 (9.3) 3 (7.0) 2 (4.7) 1 (2.3) 3 (7.0) 3 (7.0) 0 (0) 2 (4.7) 2 (4.7) 0 (0) 8 (18.6)
VAD-related infections; n (%)  • Staphylococccus aureus   • MSSA   • MRSA  • Coagulase-negative Staphylococci  • Enterobacter spp.  • Proteus mirabilis  • Escherichia coli   • ESBL  • Enterococcus spp.   • VRE  • Candida spp.  • Other	32 (74.4) 7 (16.3) 2 (4.7) 5 (11.6) 3 (7.0) 7 (16.3) 5 (11.6) 3 (7.0) 0 (0) 3 (7.0) 0 (0) 1 (2.3) 4 (9.3)

ESBL extended spectrum betalactamase, MSSA methicillin susceptible Staphylococcus aureus, MRSA methicillin resistant Staphylococcus aureus, VAD ventricular-assist device, VRE vancomycin-resistant Enterococci

^aIn 13 cases, infection was classified as being both VAD-specific and VAD-related, therefore the addition of numbers is >100 %